Live Pharmaceutical Import data of Russia imports from india under HS Code 2935909009 via Port Aviation-customs-post , our Russia customs import data reports include date, value, quantity, product description, HS code, port, country, and Russia pharmaceutical importers data
Date |
HS Code |
Product Description |
Origin Country |
Customs |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE FOR THE MANUFACTURE OF THE MEDICINAL PRODUCT "BOSENTAN", NOT FOR SALE, FOR INTERNAL USE ONLY (NOT WASTE, DOES NOT CONTAIN A RADIOACTIVE SOURCE, NOT P/M SCRAP, NOT FOR VETERINARY USE) | INDIA | AVIATION CUSTOMS POST | 8 | KG | 2994120 | Importer Name |
| 2024-04-02 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE: | INDIA | AVIATION CUSTOMS POST | 717 | KG | 5986950 | Importer Name |
| 2024-04-03 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE-POWDER /NOT FOR VETERINARY USE, NOT A Vital and Essential Drug, DOES NOT CONTAIN NARCOTIC, PSYCHOTROPIC, TOXIC OR POTENT SUBSTANCES, IS NOT WASTE/: | INDIA | AVIATION CUSTOMS POST | 125 | KG | 39500 | Importer Name |
| 2024-04-06 00:00:00 |
2935909009
|
SULFONAMIDES, NOT FOR VETERINARY USE, FOR PHARMACEUTICAL PURPOSES, NOT A MEDICINAL PRODUCT, NOT A WASTE OF CHEMICALS OR WASTE FROM THE MANUFACTURING, PREPARATION AND USE OF PHARMACEUTICAL PRODUCTS. | INDIA | AVIATION CUSTOMS POST | 0.8 | KG | 22825 | Importer Name |
| 2024-04-07 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE: | INDIA | AVIATION CUSTOMS POST | 1756 | KG | 72110140 | Importer Name |
| 2024-04-09 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE - SUMATRIPTAN (SUMATRIPTAN SUCCINATE), SUBSTANCE - POWDER. CAS No. 103628-46-2. BATCH: SMS-0080324, DATE OF PRODUCTION: MARCH 2024, EXPIRY DATE: FEBRUARY 2029 PACKED IN 2 DRUMS OF 25 KG NET EACH. | INDIA | AVIATION CUSTOMS POST | 50 | KG | 2940000 | Importer Name |
| 2024-04-11 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE-POWDER FOR THE PRODUCTION OF MEDICINES SUMATRIPTAN SUCCINATE (SUMATRIPTAN) / 25 KG. SERIES SMS-0251023 (NM). CHEMICAL NAME: [3-[2-(DIMETHYLAMINO) ETHYL] INDOLE-5-YL]-N- METHYLMETHANESULFONAMIDE SUCCINATE. | INDIA | AVIATION CUSTOMS POST | 25 | KG | 14500 | Importer Name |
| 2024-04-16 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE-POWDER /NOT FOR VETERINARY USE, NOT A Vital and Essential Drug, DOES NOT CONTAIN NARCOTIC, PSYCHOTROPIC, TOXIC OR POTENT SUBSTANCES, IS NOT WASTE/: | INDIA | AVIATION CUSTOMS POST | 1 | KG | 7900 | Importer Name |
| 2024-04-24 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE: | INDIA | AVIATION CUSTOMS POST | 754 | KG | 30963010 | Importer Name |
| 2024-04-24 00:00:00 |
2935909009
|
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE: | INDIA | AVIATION CUSTOMS POST | 1011 | KG | 41516715 | Importer Name |
2024-04-01 00:00:00
PHARMACEUTICAL SUBSTANCE FOR THE MANUFACTURE OF THE MEDICINAL PRODUCT "BOSENTAN", NOT FOR SALE, FOR INTERNAL USE ONLY (NOT WASTE, DOES NOT CONTAIN A RADIOACTIVE SOURCE, NOT P/M SCRAP, NOT FOR VETERINARY USE)
8
KG
2994120
2024-04-02 00:00:00
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE:
717
KG
5986950
2024-04-03 00:00:00
PHARMACEUTICAL SUBSTANCE-POWDER /NOT FOR VETERINARY USE, NOT A Vital and Essential Drug, DOES NOT CONTAIN NARCOTIC, PSYCHOTROPIC, TOXIC OR POTENT SUBSTANCES, IS NOT WASTE/:
125
KG
39500
2024-04-06 00:00:00
SULFONAMIDES, NOT FOR VETERINARY USE, FOR PHARMACEUTICAL PURPOSES, NOT A MEDICINAL PRODUCT, NOT A WASTE OF CHEMICALS OR WASTE FROM THE MANUFACTURING, PREPARATION AND USE OF PHARMACEUTICAL PRODUCTS.
0.8
KG
22825
2024-04-07 00:00:00
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE:
1756
KG
72110140
2024-04-09 00:00:00
PHARMACEUTICAL SUBSTANCE - SUMATRIPTAN (SUMATRIPTAN SUCCINATE), SUBSTANCE - POWDER. CAS No. 103628-46-2. BATCH: SMS-0080324, DATE OF PRODUCTION: MARCH 2024, EXPIRY DATE: FEBRUARY 2029 PACKED IN 2 DRUMS OF 25 KG NET EACH.
50
KG
2940000
2024-04-11 00:00:00
PHARMACEUTICAL SUBSTANCE-POWDER FOR THE PRODUCTION OF MEDICINES SUMATRIPTAN SUCCINATE (SUMATRIPTAN) / 25 KG. SERIES SMS-0251023 (NM). CHEMICAL NAME: [3-[2-(DIMETHYLAMINO) ETHYL] INDOLE-5-YL]-N- METHYLMETHANESULFONAMIDE SUCCINATE.
25
KG
14500
2024-04-16 00:00:00
PHARMACEUTICAL SUBSTANCE-POWDER /NOT FOR VETERINARY USE, NOT A Vital and Essential Drug, DOES NOT CONTAIN NARCOTIC, PSYCHOTROPIC, TOXIC OR POTENT SUBSTANCES, IS NOT WASTE/:
1
KG
7900
2024-04-24 00:00:00
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE:
754
KG
30963010
2024-04-24 00:00:00
PHARMACEUTICAL SUBSTANCE, NOT A WASTE, NOT FOR VETERINARY USE, NOT FOR RETAIL SALE:
1011
KG
41516715
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 2935909009 for Russia pharmaceutical imports from Thailand via Port Aviation-customs-post.
Port Aviation-customs-post typically refers to a port that is used for handling and forwarding shipments into Russia, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Russia pharmaceutical imports from india under HS code 2935909009 via Port Aviation-customs-post.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
